Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
TetraLogic Pharmaceuticals Corporation (TLOG) had Debt to Equity Ratio of -4.76 for the most recently reported fiscal year, ending 2015-12-31.
| Income Statement Financials | |
-- |
|
$-49.72M |
|
-- |
|
-- |
|
$44.99M |
|
$-44.99M |
|
$-4.73M |
|
$-49.72M |
|
$-49.72M |
|
$-49.72M |
|
$-49.72M |
|
$-49.72M |
|
$-49.72M |
|
$-44.99M |
|
$-27.90M |
|
23.69M |
|
23.73M |
|
$-2.10 |
|
$-2.10 |
|
| Balance Sheet Financials | |
$21.97M |
|
$0.42M |
|
$42.05M |
|
$64.02M |
|
$3.66M |
|
$28.28M |
|
$66.30M |
|
$69.96M |
|
$-5.94M |
|
$-47.52M |
|
$-5.94M |
|
24.77M |
|
| Cash Flow Statement Financials | |
$-34.89M |
|
$35.45M |
|
$1.79M |
|
$13.07M |
|
$15.30M |
|
$2.23M |
|
$5.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.00 |
|
-- |
|
-- |
|
1.27 |
|
|
Debt to Equity Ratio |
-4.76 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-34.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
837.00% |
|
104.65% |
|
-77.67% |
|
-222.60% |
|
$-0.24 |
|
$-1.47 |
|
$-1.47 |
|